InsiderClue
Insiders · Profile

READ IAN C

Executive Chairman at Pfizer · Director at Kimberly-Clark. Filing since 7 Feb 2007. CIK 0001372915

PFE Pfizer Executive Chairman · 14 trades KMB Kimberly-Clark Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
PFE Pfizer
4 Mar 2019
Executive Chairman
Sold, plan not stated
580,866
$25.08M
34.4%
PFE Pfizer
16 Jul 2018
Chairman & CEO
Sold, plan not stated
486,753
$18.19M
42.5%
PFE Pfizer
1 May 2018
Chairman & CEO
Sold, plan not stated
132,312
$4.76M
10.4%
PFE Pfizer
31 Aug 2017
Chairman & CEO
Sold, plan not stated
141,193
$4.80M
63.6%
PFE Pfizer
31 Aug 2017
Chairman & CEO
Sold, plan not stated
55,975
$1.90M
8.8%
PFE Pfizer
4 Aug 2017
Chairman & CEO
Sold, plan not stated
68,834
$2.34M
23.7%
PFE Pfizer
4 Aug 2017
Chairman & CEO
Sold, plan not stated
28,116
$955.94K
4.2%
PFE Pfizer
9 May 2016
Chairman & CEO
Sold, plan not stated
275,000
$9.30M
18.7%
PFE Pfizer
5 Mar 2015
Chairman & CEO
Sold, plan not stated
67,500
$2.34M
4.6%
PFE Pfizer
30 Oct 2014
Chairman & CEO
Sold, plan not stated
67,500
$2.01M
4.7%
PFE Pfizer
28 Oct 2013
Chairman & CEO
Sold, plan not stated
338,000
$10.33M
23.9%
PFE Pfizer
15 May 2013
Chairman & CEO
Sold, plan not stated
69,900
$2.05M
6.2%
PFE Pfizer
7 Nov 2007
Senior Vice President
Sold, plan not stated
20,000
$469.64K
8.2%
KMB Kimberly-Clark
29 Aug 2007
Director
Bought
700
$48.19K
opened
PFE Pfizer
7 Feb 2007
Senior Vice President
Sold, plan not stated
72,552
$1.92M
27.8%
15 decisions on file.